Document Detail


Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotion.
MedLine Citation:
PMID:  22464766     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Induction of α6β4 integrin in the differentiated epidermal cell layers in skin is a hallmark of human cutaneous squamous cell carcinoma (SCC) pathogenesis and stimulates chemically induced SCC formation in Invα6β4 transgenic mice, which exhibit persistent expression of α6β4 in the suprabasal epidermal layers. However, the molecular basis for the support of SCC development by suprabasal α6β4 is not fully understood.
OBJECTIVE: We examined the relevance for suprabasal α6β4 expression in the epidermis for the recruitment of immunosuppressive leukocytes during the early stages of tumor promotion.
METHODS: In this study, we made use of the Invα6β4 transgenic mouse model, which exhibits expression of α6β4 integrin in the suprabasal layers of the epidermis driven by the involucrin promoter. First, we examined protein lysates from Invα6β4 transgenic skin using a pro-inflammatory cytokine array panel. Next, we immunofluorescence labeling of murine skin sections was employed to immunophenotype tumor promoter-treated Invα6β4 transgenic skin. Finally, a macrophage colony stimulating factor (M-CSF) neutralizing antibody strategy was administered to resolve Invα6β4 transgenic skin inflammation.
RESULTS: Employing the Invα6β4 transgenic mouse model, we show that suprabasal α6β4 integrin expression selectively alters the profile of secreted pro-inflammatory molecules by epidermal cells, in particular CXCL5 and M-CSF, in response to acute tumor promoter treatment. The induction of CXCL5 and M-CSF in Invα6β4 transgenic epidermis was shortly followed by an exacerbated influx of CD200R(+) myeloid-derived suppressor cells (MDSCs), which co-expressed the M-CSF receptor, and FoxP3(+) Treg cells compared to wild-type mice. As a result, the levels of activated CD4(+) T lymphocytes were dramatically diminished in Invα6β4 transgenic compared to wild-type skin, whereas similar levels of lymphocyte activation were observed in the peripheral blood. Finally, 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced CD200R(+) infiltrative cells and epidermal proliferation were suppressed in Invα6β4 mice treated with M-CSF neutralizing antibodies.
CONCLUSIONS: We conclude that aberrant expression of α6β4 integrin in post-mitotic epidermal keratinocytes stimulates a pro-tumorigenic skin microenvironment by augmenting the influx of immunosuppressive granular cells during tumor promotion.
Authors:
Samar W Maalouf; Surein Theivakumar; David M Owens
Related Documents :
300026 - Description of the cells from the lymph nodes of patients with non-hodgkin's lymphoma a...
7780226 - A comparative histological and immunohistochemical study of thymomas with and without m...
7141036 - The effect of dominant hemimelia (dh) genes on the number of mast cells in lymph nodes.
9013966 - Control of leishmania major infection in balb/c mice by inhibition of early lymphocyte ...
20212116 - Membrane nanotubes facilitate long-distance interactions between natural killer cells a...
11494036 - Cd3+cd56+cd8+ cells demonstrating a suppressor t cell-like function in the peripheral b...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-02-27
Journal Detail:
Title:  Journal of dermatological science     Volume:  66     ISSN:  1873-569X     ISO Abbreviation:  J. Dermatol. Sci.     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-17     Completed Date:  2012-08-09     Revised Date:  2013-06-26    
Medline Journal Info:
Nlm Unique ID:  9011485     Medline TA:  J Dermatol Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  108-18     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Dermatology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antigens, Surface / metabolism
Carcinogens / toxicity
Carcinoma, Squamous Cell / etiology,  immunology*,  pathology
Chemokine CXCL5 / metabolism
Epidermis / immunology*,  pathology
Gene Expression
Humans
Inflammation Mediators / metabolism
Integrin alpha6beta4 / genetics,  immunology*
Keratinocytes / immunology,  pathology
Lymphocyte Activation
Macrophage Colony-Stimulating Factor / antagonists & inhibitors,  metabolism
Mice
Mice, Transgenic
Myeloid Cells / immunology,  pathology
Receptors, Cell Surface / metabolism
Recombinant Proteins / genetics,  immunology
Skin Neoplasms / etiology,  immunology*,  pathology
T-Lymphocytes / immunology
T-Lymphocytes, Regulatory / immunology,  pathology
Tetradecanoylphorbol Acetate / toxicity
Tumor Microenvironment / immunology
Grant Support
ID/Acronym/Agency:
R01 CA114014/CA/NCI NIH HHS; R01 CA114014-01A2/CA/NCI NIH HHS; R01 CA114014-02/CA/NCI NIH HHS; R01 CA114014-03/CA/NCI NIH HHS; R01 CA114014-04/CA/NCI NIH HHS; R01 CA114014-05/CA/NCI NIH HHS; R01CA114014/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, Surface; 0/Carcinogens; 0/Cd200r1 protein, mouse; 0/Chemokine CXCL5; 0/Cxcl5 protein, mouse; 0/Inflammation Mediators; 0/Integrin alpha6beta4; 0/Receptors, Cell Surface; 0/Recombinant Proteins; 16561-29-8/Tetradecanoylphorbol Acetate; 81627-83-0/Macrophage Colony-Stimulating Factor
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036...
Next Document:  Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fracti...